Fengsen Li
Impact in
- Emergency Medical Services top 5%
- Pediatric health and respiratory diseases
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 22
- Respiratory Support and Mechanisms 8
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Immunology 14
- IL-33, ST2, and ILC Pathways 9
- Immune Cell Function and Interaction 5
- Co-authors
- Jianbing Ding (15 shared papers)Jing Jing (23 shared papers)Zheng Li (21 shared papers)Min Jiang (7 shared papers)Fengbo Zhang (6 shared papers)Zhen Gao (11 shared papers)Pei Li (3 shared papers)Fan Wang (3 shared papers)
- Journals
- International Journal of COPD (9 papers)Evidence-based Complementary and Alternative Medicine (5 papers)Combinatorial Chemistry & High Throughput Screening (3 papers)Medicine (3 papers)Frontiers in Immunology (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Fengsen Li
56 papers receiving 532 citations
Peers
Comparison fields: 5 of 84
- Emergency Medical Services 60
- Complementary and alternative medicine 65
- Pulmonary and Respiratory Medicine 239
- Immunology 129
- Pharmacology 39
Countries citing papers authored by Fengsen Li
This map shows the geographic impact of Fengsen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengsen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengsen Li more than expected).
Fields of papers citing papers by Fengsen Li
This network shows the impact of papers produced by Fengsen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengsen Li. The network helps show where Fengsen Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengsen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 32 | |
| 2 | 2019 | 30 | |
| 3 | 2014 | 29 | |
| 4 | 2010 | 28 | |
| 5 | 2016 | 21 | |
| 6 | 2020 | 21 | |
| 7 | 2023 | 19 | |
| 8 | 2023 | 18 | |
| 9 | 2014 | 18 | |
| 10 | 2014 | 17 | |
| 11 | 2016 | 16 | |
| 12 | 2016 | 15 | |
| 13 | 2023 | 15 | |
| 14 | 2020 | 15 | |
| 15 | 2017 | 14 | |
| 16 | 2021 | 14 | |
| 17 | 2018 | 13 | |
| 18 | 2018 | 13 | |
| 19 | 2024 | 12 | |
| 20 | Use of aquaporins 1 and 5 levels as a diagnostic marker in mild-to-moderate adult-onset asthma. | 2015 | 12 |
About Fengsen Li
Fengsen Li is a scholar working on Pulmonary and Respiratory Medicine, Immunology, Emergency Medical Services, Molecular Biology and Complementary and alternative medicine, having authored 59 papers that have together received 540 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Pediatric health and respiratory diseases (13 papers), IL-33, ST2, and ILC Pathways (9 papers), Asthma and respiratory diseases (8 papers), Respiratory Support and Mechanisms (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Traditional Chinese Medicine Studies (6 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Emergency Medical Services (60 citations), Complementary and alternative medicine (65 citations), Pulmonary and Respiratory Medicine (239 citations), Immunology (129 citations) and Pharmacology (39 citations). Fengsen Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jianbing Ding, Jing Jing, Zheng Li, Min Jiang, Fengbo Zhang, Zhen Gao, Pei Li, Fan Wang, Jing Wang and Halmurat Upur. Their work appears in journals such as International Journal of COPD, Evidence-based Complementary and Alternative Medicine, Combinatorial Chemistry & High Throughput Screening, Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.